Amivantamab (Anti-HGFR / c-Met)

Amivantamab (Anti-HGFR / c-Met) is a human bispecific antibody targeting EGFR-MET.It has immune anticancer activity in non-small cell lung cancer (NSCLC). MW :146.1 KD.
Supplier Selleck Chemicals
Product # A2601
Sku # A2601-1mg*5
Pricing 1mg*5, $970.00
Feedback